ArticleOncotarget2020

Potential use of lenvatinib for patients with unresectable hepatocellular carcinoma including after treatment with sorafenib: Real-world evidence and

Tetsu Tomonari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.